dactinomycin has been researched along with Adenocarcinoma Of Kidney in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbes, I; Barsaoui, S; Ben Romdhane, K; Braham, E; Hannachi Sassi, S; Mrad, K; Oubiche, F | 1 |
Iwashita, K; Kubo, M; Oyachi, N; Oyama, T; Yamamoto, T | 1 |
Ebert, A; Gravou, C; Rösch, WH; Stümpfl, M | 1 |
Akyuz, C; Buyukpamukçu, M; Buyukpamukçu, N; Cağlar, M; Sari, N; Varan, A | 1 |
Bastian, PJ; Biermann, K; Bode, U; Ellinger, J; Fischer, N; Hadizadeh, D; Müller, SC; Simon, A | 1 |
Obiri, NI; Puri, RK | 1 |
Hashimoto, Y; Kato, K; Kumamoto, Y; Tsukamoto, T; Yanase, M | 1 |
Christosova, I; Kiourktchieva, S; Minkov, N; Rousseva, T | 1 |
Klausner, RD; Lee, S; Neumann, M; Pause, A; Pavlakis, GN; Stauber, R; Stearman, R | 1 |
Altieri, DC; Azuhata, T; Fialkov, JM; Griffith, TS; Sandler, AD; Scott, DL; Wall, NR; Williams, RD | 1 |
Gabriel, D; Klatte, D; Müller, GW; Redmann, K; Richter, A | 1 |
11 other study(ies) available for dactinomycin and Adenocarcinoma Of Kidney
Article | Year |
---|---|
[Clear-cell sarcoma of the kidney. Two pediatric cases].
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Child, Preschool; Combined Modality Therapy; Dactinomycin; Humans; Infant; Kidney Neoplasms; Male; Treatment Outcome; Vincristine | 2008 |
Two different types of infantile renal cell carcinomas associated with tuberous sclerosis.
Topics: Angiofibroma; Angiomyolipoma; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Renal Cell; Combined Modality Therapy; Dactinomycin; Diagnostic Errors; Facial Neoplasms; Female; Genetic Predisposition to Disease; Humans; Infant; Intellectual Disability; Kidney Neoplasms; Liver Neoplasms; Male; Molecular Sequence Data; Neoplasms, Second Primary; Nephrectomy; Polycystic Kidney Diseases; Seizures, Febrile; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Vincristine; Wilms Tumor | 2011 |
[Renal cell carcinoma in childhood. Case report and review].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Child; Combined Modality Therapy; Dactinomycin; Diagnostic Imaging; Diseases in Twins; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Nephrectomy; Vincristine | 2003 |
Renal cell carcinoma in children: experience of a single center.
Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Renal Cell; Child; Child, Preschool; Cisplatin; Dactinomycin; Female; Fluorouracil; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Retrospective Studies; Survival Analysis; Treatment Outcome; Ureter | 2007 |
[Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Child; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Nephrectomy; Ultrasonography; Vincristine; Wilms Tumor | 2008 |
Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Topics: Carcinoma, Renal Cell; Cell Division; Cycloheximide; Dactinomycin; Humans; Interleukin-4; Iodine Radioisotopes; Kidney Neoplasms; Lymphocyte Activation; Lymphoid Tissue; Lymphoma, B-Cell; Lymphoma, T-Cell; Receptors, Interleukin-4; Receptors, Mitogen; Stimulation, Chemical; T-Lymphocytes; Tumor Cells, Cultured | 1994 |
Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Adhesion Molecules; Cell Communication; Combined Modality Therapy; Dactinomycin; Humans; Immunotherapy, Adoptive; Intercellular Adhesion Molecule-1; Interferon-gamma; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Recombinant Proteins; Sensitivity and Specificity; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
[Late results of the complex treatment of primary kidney neoplasm in children].
Topics: Age Factors; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Staging; Nephrectomy; Remission Induction; Splenic Neoplasms; Survival Rate; Treatment Outcome; Vincristine; Wilms Tumor | 1997 |
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
Topics: Animals; Base Sequence; Biological Transport, Active; Carcinoma, Renal Cell; Cell Fusion; Cell Nucleus; COS Cells; Cytoplasm; Dactinomycin; DNA Primers; Genes, Tumor Suppressor; Green Fluorescent Proteins; HeLa Cells; Humans; Kidney Neoplasms; Ligases; Luminescent Proteins; Mutation; Proteins; Recombinant Fusion Proteins; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 1999 |
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Renal Cell; Chromosomal Proteins, Non-Histone; Dactinomycin; Drug Synergism; Female; Humans; Inhibitor of Apoptosis Proteins; Kidney Neoplasms; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Protein Synthesis Inhibitors; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
[Pretherapeutic testing of sensitivity to cytostatic drugs in primary cultures of selected urologic tumors].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Renal Cell; Cell Survival; Cisplatin; Colony-Forming Units Assay; Dactinomycin; Dose-Response Relationship, Drug; Humans; Kidney Neoplasms; Male; Membrane Potentials; Testicular Neoplasms; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine | 1986 |